MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$60,192K
EPS
-$1.32
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
53,435
53,684
57,067*
27,094
General and administrative
10,113
10,819
17,522*
4,404
Total operating expenses
63,548
64,503
74,589
31,498
Loss from operations
-63,548
-64,503
-74,589*
-31,498
Interest income
2,349
2,472
871*
1,549
Other income, net
1,007
1,363
820*
531
Total other income, net
-
-
1,691*
2,080
Net loss
-60,192
-60,668
-72,898
-29,418
Basic EPS
-1.32
-1.34
-4.399
-37.18
Diluted EPS
-1.32
-1.34
-4.399
-37.18
Basic Average Shares
45,431,359
45,276,763
16,570,355
791,127
Diluted Average Shares
45,431,359
45,276,763
16,570,355
791,127
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$60,192K
Interest income
$2,349K
Other income, net
$1,007K
Loss from operations
-$63,548K
Total operating
expenses
$63,548K
Research and development
$53,435K
General and
administrative
$10,113K
Buy us a coffee
MapLight Therapeutics, Inc. (MPLT)
MapLight Therapeutics, Inc. (MPLT)